USSA-AVAA 2024 Abstract Submission
If you submitted an abstract to ANESTHESIOLOGY® 2024, a separate submission of your abstract to the USSA/AVAA annual meeting is explicitly permitted by ASA, USSA and AVAA. Fill out one form per submission using the contact information of the author who will receive all correspondence related to the submission acceptance and scheduling. Please use author contact information that will still be effective on October 18,2024. All forms must be submitted by Sunday, June 23, 2024 (11:59 p.m. CT).
Corresponding Author
Full Name
*
First Name
Last Name
Credentials
Email
*
example@example.com
Phone Number
*
Please enter a valid phone number.
Address
*
Street Address
Street Address Line 2
City
State / Province
Postal / Zip Code
Is the Corresponding Author the same person as the Presenting Author?
*
Yes
No
Presenting Author
If the Presenting Author is not the same person as the Corresponding Officer, please fill out the fields in this section.
Full Name
First Name
Last Name
Credentials
Email
example@example.com
Phone Number
Please enter a valid phone number.
Address
Street Address
Street Address Line 2
City
State / Province
Postal / Zip Code
Please select your abstract type.
*
Scientific Study
Medically Challenging Case
Abstract Title
*
Note: All abstract titles must be in English.
Author(s)
*
Note: Please list all the authors here.
Institution(s)
*
Note: Please list all the institutions for all authors here (in order).
Abstract Summary
*
Please enter ONLY the abstract summary. The summary should be a 2-3 line summary/description of your abstract that may only appear on the USSA/AVAA Annual Academic Meeting website. The material will not be considered in the grading or acceptance process for abstracts.
0/800
Upload Abstract Here (please do not include authors and institutions). Files accepted: Word doc, docx, PDF.
*
Browse Files
Drag and drop files here
Choose a file
Cancel
of
Attestations
If my abstract is accepted, I (or a co-author) will attend the Academic Meeting on October 18, 2024 in Philadelphia or a co-author or colleague will attend in my place. In case there is a change in the presenter, I will contact Brittney Conway at b.conway@asahq.org as soon as it is known to ensure timely change. I agree.
*
Yes
No
I understand that I must contact the USSA/AVAA personnel with any requests to make changes to my submission after the June 23, 2024 deadline. Changes will be reviewed and accepted on a case-by-case basis. Typically, only minor changes, grammatical changes, or changes to authors will be made. I will contact Brittney Conway at b.conway@asahq.org with all change requests. DEADLINE FOR ALL CHANGES: Friday, July 5, 2024. I agree.
*
Yes
No
Should I have a scheduling conflict, I understand that abstracts cannot be rescheduled for a different day/time. A co-author may be appointed as the presenter if the primary author cannot present. I agree.
*
Yes
No
If the USSA/AVAA Academic Meeting Abstract Review Committee withdraws my abstract for reasons including, but not limited to, irregularities or misconduct, I understand that I may not submit an abstract for the following year. I agree.
*
Yes
No
USSA/AVAA Academic Meeting Policy on Scientific Abstracts: I understand that abstracts submitted for presentation at the USSA/AVAA Academic Meeting must not have been published prior to October 1, 2024 at any local, national or international meeting* or broadcasted or published, in print or digital format, including journals, newsletters, news media coverage and education products. Internal presentations to small groups within the authors’ institution are permitted. For inquiries regarding news releases on these abstracts, please contact Brittney Conway at b.conway@asahq.org. I agree.
*
Yes
No
I understand that the following USSA/AVAA 2024 Academic Annual Meeting Scientific Abstract Embargo Policy applies: Embargo policies have been adopted from the ASA annual meeting guidance in that all scientific abstracts accepted for presentation are embargoed (may not be published or publicized) until the date and time of presentation. I agree.
*
Yes
No
By submitting an abstract on this USSA/AVAA website, you represent that you own or otherwise have the rights to the written summaries of research or observations ("Abstract") you provided to the USSA/AVAA on this site. USSA/AVAA acknowledges and agrees that as between USSA/AVAA and you, you own all right, title and interest of any nature, throughout the world, in and to the Abstract, including any copyright registration or applications for copyright registrations relating thereto anywhere in the world. You grant to USSA/AVAA anon-exclusive, perpetual, sub-licensable, worldwide, right and license (or sublicense, as the case may be) to use, copy, modify, reproduce, publicly display, publicly perform, transmit, distribute or otherwise make available the Abstract in any form or format, including without limitation, through the Internet on various websites of USSA/AVAA and USSA/AVAA’s licensees or USSA/AVAA’s affiliates, intranets, and any other technologies whether now known or developed in the future; and to permit end-users to copy, display and print it for their own personal or business use (but not for resale by any such end-user). I agree.
*
Yes
No
For Scientific Studies and Medically Challenging Case Reports, please indicate your answer to the following statement: I have satisfied the requirements of my institution or organization regarding the use of human subjects or animals in research and received approval of the Internal Review Board (IRB) or Institutional Animal Care and Use Committee (IACUC) respectively.
*
Yes
No
I understand that as the corresponding author my email address may be shared with the moderator(s) of the session if my submission is accepted. Moderators may contact presenters prior to the conference regarding their presentation.
*
Yes
No
By signing and dating the fields below you acknowledge that you agree to the information above and have answered it to the best of your ability.
*
Email
*
example@example.com
Signature Date
*
-
Month
-
Day
Year
Date
Continue
Continue
Should be Empty: